BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 5005707)

  • 1. [Resistance and virulence of mycobacteria. Clinical and experimental studies].
    Lucchesi M
    Ftiziologia; 1971; 20(4):401-4. PubMed ID: 5005707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relations between resistance and virulence of mycobacteria].
    Daddi G
    Arch Monaldi; 1972; 27(4):426-35. PubMed ID: 4217599
    [No Abstract]   [Full Text] [Related]  

  • 3. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs].
    Bibik NF
    Probl Tuberk; 1972; 50(8):20-5. PubMed ID: 4626690
    [No Abstract]   [Full Text] [Related]  

  • 4. [Virulence of polyresistant strains of Mycobacterium tuberculosis].
    Drabkina RO; Klimenko MT
    Probl Tuberk; 1978 Nov; (11):70-5. PubMed ID: 103091
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
    Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM; Margadze GKh; Zautashvili MG
    Probl Tuberk; 1975; (3):79. PubMed ID: 124432
    [No Abstract]   [Full Text] [Related]  

  • 11. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance to antitubercular agents in patients with pulmonary tuberculosis treated in the period from 1967 to 1970].
    Marsenić B; Panajotović H
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():60-7. PubMed ID: 4216923
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K; Piotrowski Z; Szymański A
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary drug resistance of tuberculosis mycobacteria].
    Fedotova ZN; Kerpel' RS
    Probl Tuberk; 1971; 49(11):33-7. PubMed ID: 5004856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
    Daddi G; Lucchesi M; Maldarizzi B; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(4):286-300. PubMed ID: 5004328
    [No Abstract]   [Full Text] [Related]  

  • 16. [The virulence of resistant strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. I. The virulence of the resistant strains of Mycobacterium tuberculosis].
    Wang XG
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):204-6. PubMed ID: 6816557
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B
    Plucne Bolesti; 1985; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of laboratory and clinical antitubercular agent sensitivity tests].
    Popovic J; Praso R; Stosic Z; Davidovic C
    Plucne Bolesti Tuberk; 1971; 23(4):333-8. PubMed ID: 5004987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Response of Mycobacteria tuberculosis isolated from chronic patients to single or combined drugs].
    Fanea E; Vaida T; Buzilă A; Bukşe E; Câmpeanu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):335-42. PubMed ID: 6304848
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.